Frank Vandendriessche graduated as pharmacist at the KULeuven (B) where he also obtained a PhD degree in pharmaceutical sciences based on medicinal chemistry research work on antiviral nucleosides and oligonucleotides. Between 1994 and 2014, he worked in the pharmaceutical industry for three vaccine companies i.e. Pfizer Animal Health, GSK Biologicals and Merck/MSD where he was continuously involved in quality and regulatory aspects of vaccines. Since 2014 he works as consultant in regulatory affairs, with continued activities in the same area of both prophylactic and therapeutic human vaccines, for large pharmaceutical companies, small biotech start-ups as well as NGO's. He has been regularly assigned as regulatory project lead and contact person to the European Regulatory Authorities. In addition to projects related to vaccines, he provided support for other biologicals and biosimilars as well as human medicines in the oncology and anti-infectious disease areas. He followed additional courses on EBM as well as HTA.
His primary role since 2022 has been to act as Chief Regulatory Officer of Vicebio, a start-up working on vaccines for prevention of respiratory viral infections and diseases.
Since mid 2024 he supports the IABS Human Vaccine Committee as a volunteer.